The media headlines are screaming about a "brand new, terrifying super-drug" hitting the streets that makes fentanyl look like baby aspirin. The talking heads call it an unprecedented chemical mystery.
It is neither new nor a
mystery.
The drug is cychlorphine
(chemically designated as N-propionitrile chlorphine). It is not the brainchild
of a rogue street chemist or a dark-web prodigy. It is a 66-year-old
pharmaceutical discard.
Back in the late 1950s
and 1960s, commercial pharmaceutical laboratories in Belgium and across Europe
were racing to discover potent painkillers that could tame the excruciating
agony of terminal cancer and major orthopedic trauma. During that same era, Dr.
Paul Janssen synthesized fentanyl. Fentanyl worked: it was roughly 100 times
stronger than morphine, but it possessed a manageable safety margin. In a
hospital surgical suite with an anesthesiologist monitoring an oxygen line, it
could be controlled.
In that exact same wave
of 1960s research, scientists mapped out the "orphine" chemical
family, giving birth to compounds like brorphine, chlorphine, and cychlorphine.
But while fentanyl went to the hospital pharmacy, cychlorphine was tossed straight
into the biohazard bin. Why? Because its therapeutic window did not exist. In
plain English: the dose required to relieve pain and the dose that permanently
turned off the brain's breathing reflex were essentially identical. It was
abandoned because it was not a medicine; it was a biological death sentence.
Now, six decades later,
it has been pulled off library microfiche to feed an insatiable illicit supply
chain.
THE POTENCY SCALE
Public health advisories
from the White House Office of National Drug Control Policy (ONDCP) and the
Center for Forensic Science Research and Education (CFSRE) estimate
cychlorphine at roughly 10 times more potent than fentanyl. That translates to
roughly 500 to 1,000 times the potency of standard medical morphine.
THE STREET NAME ILLUSION
The public imagines
dealers standing on street corners peddling bags stamped
"Cychlorphine." That is pure fantasy. You will never hear a
street-level buyer ask for it, and the dealer selling it does not even know it
is in the bag. Cychlorphine is an invisible, upstream phantom. It is blended
into bulk powders to boost weak batches or pressed into counterfeit blue
"M30" oxycodone, Xanax, or Percocet pills destined for suburban
bedrooms, college dorms, and urban encampments.
THE RAPID-FIRE POISONING
REALITY
A single grain of common
table salt weighs around 60 micrograms. A lethal dose of cychlorphine is
smaller than that single grain. When a human body encounters an opioid of this
magnitude, there is no prolonged nod, no gradual drift into sleep, and no desperate
gasp for breath. The compound binds to the brainstem's opioid receptors with
terrifying speed, instantly paralyzing the respiratory center.
The tragic irony? While
public health bureaucrats pat themselves on the back for distributing fentanyl
test strips (FTS), cychlorphine is chemically invisible to standard fentanyl
test strips and routine 10-panel hospital urine screens. The test strip comes
up clean, the user believes the pill is safe, and within three minutes the
coroner is called.
INDUSTRIAL SYNTHESIS,
POSTAL VECTORS, AND THE PILL-PRESS ASSEMBLY LINE
The second great illusion
sold to the public is that illicit drugs are cooked up by local crews in
neighborhood basements. Nobody is synthesizing cychlorphine in an American
garage. The modern illicit market operates like an agile transnational
corporation, relying on global chemical arbitrage, micro-parcel logistics, and
domestic mechanical assembly.
THE OVERSEAS CHEMICAL
FOUNDRY
The actual chemical
synthesis takes place thousands of miles away, predominantly inside
commercial-grade chemical facilities and rogue laboratory complexes operating
across China. When international law enforcement tightened restrictions on
traditional fentanyl precursors like 4-ANPP, and especially after China enacted
class-wide controls on nitazene-class opioids in July 2025, foreign chemical
syndicates simply pivoted to past scientific literature. They pulled
non-scheduled 1960s orphine compounds like cychlorphine off the shelf. Because
cychlorphine relies on generic, unmonitored industrial reagents rather than
flagged fentanyl building blocks, foreign export operations can manufacture the
finished active pharmaceutical ingredient legally or semi-legally under the
guise of commercial research chemicals.
MICRO-PARCELS AND CARTEL
SUPPLY PIPELINES
Transporting legacy
plant-based drugs like cannabis, cocaine, or crude black-tar heroin
historically required subterranean tunnels, cargo shipping containers, and
heavily compromised border crossings. Moving cychlorphine requires nothing more
than an envelope. Because cychlorphine is ten times more potent than fentanyl,
a single kilogram of pure powder contains millions of fatal doses. Overseas
suppliers package pure, off-white cychlorphine powder into modest express
airmail shipments, disguised as industrial toner, cosmetic mica, or raw plastic
pigments. These packages slip straight through standard international mail
sorting facilities directly into American cities. At the same time, major
transnational syndicates, including the Sinaloa and Jalisco New Generation
networks, have incorporated these pure orphine consignments into their
wholesale distribution hubs to reinforce depleted fentanyl stocks and maximize
chemical hook across retail distribution lines.
THE DOMESTIC MECHANICAL
MILL
Once the concentrated
chemical reaches domestic soil, local networks perform no organic chemistry
whatsoever. Their role is purely mechanical: cutting, blending, and pressing.
Operating out of suburban rental homes, garages, and nondescript industrial park
bays across the country, processing crews use commercial ribbon blenders to
stretch microscopic amounts of cychlorphine across pounds of inert tableting
binders, such as microcrystalline cellulose, lactose, and cornstarch. They
frequently toss in cheap illicit stimulants like methamphetamine or
black-market tranquilizers like bromazolam and xylazine to tweak the perceived
profile of the high. From there, industrial rotary pill presses outfitted with
counterfeit pharmaceutical dies stamp out roughly ten thousand counterfeit
prescription pills an hour.
THE CHOCOLATE CHIP COOKIE
HAZARD
Clandestine tableting
operations possess none of the micro-blending standards or strict quality
controls demanded of legitimate pharmaceutical plants. When a baker mixes
chocolate chips into cookie dough by hand, the chips never distribute with
mathematical equality; one cookie ends up with two chips, while another ends up
with twenty. In a production run of fifty thousand pressed counterfeit tablets,
uneven blending leaves microscopic clumps of pure cychlorphine scattered
throughout the batch, creating lethal hotspots. One counterfeit pill may
deliver a mild, muted effect, while the next pill off the tray contains five
hundred micrograms—a concentrated payload sufficient to shut down the
respiratory drive of multiple adults before the tablet has even dissolved in
the stomach.
CLINICAL TOXICOLOGY,
COMPARATIVE HISTORY, AND FATAL POLYSUBSTANCE DYNAMICS
The divergence between
fentanyl and cychlorphine comes down to a fundamental medical dividing line:
the width of the therapeutic safety window.
THE FENTANYL TRAJECTORY
VERSUS CYCHLORPHINE'S HISTORICAL ABANDONMENT
Dr. Paul Janssen
synthesized fentanyl in Belgium in 1959–1960 to solve an operating-room crisis:
morphine was too slow to kick in, hung around in the body too long, and caused
dangerous drops in blood pressure. Fentanyl was roughly 100 times stronger than
morphine, but it acted in minutes, left the cardiovascular system stable, and
cleared quickly. It offered a predictable therapeutic window—the safety margin
between relieving severe pain and stopping the lungs. In controlled surgical
theaters with mechanical ventilators, anesthesiologists could dial it in
safely, eventually leading to its approval for terminal cancer pain in the
1990s.
During that same
pharmaceutical era, researchers hunting for ultra-potent analgesics synthesized
the orphine family, including cychlorphine. It was permanently shelved because
its therapeutic index was virtually zero. The dose required to control intractable
cancer pain was indistinguishable from the dose that paralyzed the brain's
breathing reflex. In lay terms: fentanyl was a sharp scalpel that could be
guided safely by a trained doctor; cychlorphine was an uncontrolled
sledgehammer that suffocated test subjects almost instantaneously.
LETHALITY IN PRACTICAL
TERMS
If standard medical
morphine is a drop of water, fentanyl is a shot glass, and cychlorphine is a
firehose. Cychlorphine is estimated at 500 to 1,000 times stronger than
morphine and roughly 10 times stronger than fentanyl. Medical examiners have
documented fatal poisonings with blood concentrations as minuscule as 0.5
nanograms per milliliter, which represents half of one-billionth of a gram. A
lethal dose is invisible to the human eye, measuring smaller than a single
grain of baker's salt.
RECEPTOR MECHANICS AND
THE LOCKED CHEST
Once introduced into the
bloodstream, cychlorphine floods the brainstem’s 
-opioid receptors with
extreme binding grip and affinity. It immediately shuts off the body's internal
carbon dioxide alarm system. A person does not feel air hunger or choke; they
simply fall into a coma within seconds as their respiratory rate drops from
twelve to sixteen breaths per minute straight to zero. Like other ultra-potent
synthetics, intense receptor binding can trigger acute chest-wall rigidity,
commonly referred to as wooden chest syndrome. In this state, the intercostal
muscles lock up entirely, turning the ribcage rigid and making unassisted
rescue breathing mechanically impossible without immediate pharmacological
reversal and intubation.
INTERACTIONS WITH
MEDICATION-ASSISTED TREATMENT REGIMENS
When it comes to
buprenorphine, the primary ingredient in Suboxone, the drug operates as a
partial agonist with a very tight receptor grip designed to block other street
opioids. However, when an individual stable on Suboxone unknowingly ingests
cychlorphine, cychlorphine's sheer mass-action potency can punch right through
the buprenorphine blockade. Because the individual assumes they are
pharmacologically protected, an unexpected, catastrophic overdose can occur
without warning.
With methadone, the risk
profile changes entirely. Methadone is a long-acting, full opioid agonist that
builds up in bodily tissue over time, offering no ceiling effect on respiratory
depression. Taking cychlorphine on top of daily methadone creates compounded
full-agonist toxicity, causing the brain's respiratory drive to collapse under
the combined weight of two long-acting, ultra-potent depressants operating at
the same time.
As for pure narcotic
antagonists like naloxone, the antidote does not induce death or cause a toxic
chemical reaction. It remains the frontline rescue agent. However, because
cychlorphine clings to brain receptors with profound tenacity, standard 4-milligram
nasal sprays often get bounced off the receptor site. First responders
routinely report that victims require three, four, or more successive doses of
naloxone alongside bag-valve-mask ventilation to displace the compound and
restore spontaneous respiration.
THE FATAL MULTIPLIER AND
POLYSUBSTANCE SATURATION
The single most lethal
combination encountered with cychlorphine is co-ingestion with central nervous
system depressants, specifically benzodiazepines like alprazolam and illicit
bromazolam, or veterinary tranquilizers like xylazine. Because naloxone only
reverses the opioid receptor component, it cannot reverse the cellular shutdown
caused by heavy sedatives, locking the body into irreversible hypoxia before
emergency personnel can arrive on scene. Forensic post-mortem casework from
regional death clusters confirms that decedents are overwhelmingly
polysubstance saturated. In the vast majority of documented cychlorphine
deaths, toxicological screens reveal a lethal mixture of cychlorphine combined
with illicit fentanyl, methamphetamine taken to counteract the extreme sedative
drop, cocaine, and designer sedatives, with pure cychlorphine appearing as a
solitary agent in only a minor fraction of autopsies.
THE
PREDICTABLE OVERDOSE: HOW DESTROYING RECOVERY MANUFACTURED A $35.9 TRILLION
BODY COUNT
The arrival of
cychlorphine is not an unpredictable act of chemical fate. It is the
mathematically engineered end-state of a 26-year institutional collapse: the
systematic eradication of authentic, abstinence-based recovery in America. When
a regulatory apparatus spends two and a half decades dismantling programs that
produce sober, self-sufficient human beings, it does not solve an addiction
crisis. It constructs an industrial pipeline that delivers living individuals
directly to the county morgue.
THE ERASURE OF ABSTINENCE
AND THE $35.9 TRILLION MONOPOLY
For the better part of
the twentieth century, the benchmark of addiction treatment was rooted in an
uncompromising objective: complete, unadulterated sobriety. Anchored in
rigorous residential immersion, twelve-step integration, radical self-honesty,
and emotional maturity, long-term abstinence-based programs historically
produced sustained recovery rates between 51% and 91% for individuals who fully
worked the process. Millions of people—from celebrated rock icons like Joe
Walsh to everyday tradespeople, attorneys, and parents—reclaimed their lives,
re-entered the economy, raised families, and stayed clean for twenty, thirty,
or forty years without asking society to pay for recurring emergency
interventions or state-funded maintenance doses.
That proven paradigm was
dismantled to clear the path for a lucrative pharmaceutical extraction model.
Over the last quarter-century, an entrenched alliance of regulatory architects,
academic grant recipients, and pharmaceutical corporations systematically
rebranded abstinence as an outdated, punitive relic. Under the deceptive banner
of "harm reduction" and lifelong Medication-Assisted Treatment, real
recovery was redefined as perpetual chemical management. Centers for Medicare
& Medicaid Services billing codes were expanded, commercial insurance
mandates fell into lockstep, and public health policy declared that chemical
dependence could only be managed by trading street narcotics for
state-sanctioned synthetic opioids. The economic devastation of this shift is
monumental. Across the broader economy, the cumulative damages and
institutional extractions of this engineered crisis represent a staggering
$35.9 trillion drain—a colossal transfer of public and private wealth that has
enriched clinical conglomerates while leaving families financially gutted and
utterly devastated.
WALKING IN PERPETUAL
RELAPSE: THE POLYPHARMACY TRAP
The fundamental deception
of the modern symptom management paradigm is the claim that an individual
stabilized on daily synthetic narcotics is safe from catastrophic street drugs.
In truth, an individual maintained on an MAT protocol is walking through life
in a chemically compromised, partially wasted baseline state. Because the
underlying spiritual, emotional, and behavioral roots of addiction are left
untouched by a daily pharmaceutical dose, the individual is effectively living
in permanent pre-relapse. When the inevitable personal crisis hits—a broken
relationship, the loss of employment, a death in the family, or simply a
prolonged period of deep emotional despair—the biological instinct to numb
reality takes over.
Compounding this
psychological vulnerability is a routine, clinical reality: the contemporary
patient is rarely taking just a single maintenance drug. Instead, they are
chemically saturated with complex psychiatric cocktails. It is routine to find
individuals prescribed combinations of high-dose buprenorphine or methadone,
massive daily dosages of gabapentinoids, sleep-inducing sedatives, and
mood-altering psychiatric agents. In clinical practice, these combinations
routinely drive a patient's total central nervous system depressant load 400%
or more beyond standard Physicians' Desk Reference and DEA safety baselines.
These individuals are not living in stable recovery; they are balancing on a
razor-thin toxic bell curve, where their respiratory system is already
functioning near critical capacity.
FROM HARM REDUCTION TO
HORIZONTAL CORPSE: THE MICROSCOPIC TRIGGER
When a person whose
central nervous system is already suppressed by daily methadone or high-dose
buprenorphine crosses paths with cychlorphine, the biological margin for
survival disappears entirely. Consider the practical reality of what it takes
to transition from supposed "harm-reduction maintenance" to a
horizontal corpse on an autopsy table. A single grain of common baker's salt
weighs roughly 60 micrograms. If you were to take that single grain of salt and
crush it into a dozen microscopic dust particles, just one of those airborne
flecks represents an active lethal dose of cychlorphine for a chemically naive
person.
For someone already
sitting on the toxic bell curve—whose blood is carrying an around-the-clock
load of prescribed opioids, anti-anxiety tranquilizers, and
antidepressants—that microscopic threshold shrinks even further. It does not
require a full pressed tablet or a noticeable line of powder to overwhelm the
system. In this pre-saturated biological state, the addition of a
sub-microscopic trace of cychlorphine, an amount literally invisible to the
human eye, exerts an instantaneous, overwhelming displacement on brainstem
receptors. The individual does not even have the physiological reserve to
execute a struggle. The respiratory drive terminates immediately, the ribcage
seizes into rigidity, and cardiac arrest follows within minutes. The system
promised them safety; the pharmacology delivers instant asphyxiation.
INSTITUTIONAL COMPLICITY:
DRUG COURTS AND THE TWO-YEAR DEATH PROJECTION
This lethal mechanism is
not merely occurring on forgotten street corners; it is actively enforced by
institutional authority. Across the nation, specialized drug courts,
probationary diversion programs, and municipal criminal justice mechanisms have
largely ceased utilizing non-punitive referrals to long-term, abstinence-based
therapeutic communities. Instead, compliance is frequently tied directly to
enrolling in Medicaid-reimbursed MAT clinics. Traditional, twelve-step,
faith-based, or long-term abstinence recovery centers have been starved of
resources, de-credentialed, or driven out of operation by state regulatory
bodies that refuse to certify facilities that do not distribute pharmaceutical
narcotics. Society has intentionally eliminated the only off-ramp that leads to
complete sobriety.
Under these current
protocols, the trajectory for the next two years is mathematically grim. With
cychlorphine establishing an irreversible foothold in the illicit supply chain,
and with traditional abstinence-based recovery remaining virtually inaccessible
to the average citizen caught in the court system, a standard probability index
indicates that fatal drug overdoses will accelerate an additional 25% to 40%
across impacted metropolitan corridors over the next 24 months. When policy
artificially preserves a population in a state of perpetual chemical
dependence, it guarantees an unrelenting market demand. And when that consumer
demand collides with a 66-year-old laboratory discard that is ten times more
lethal than fentanyl, the outcome is not an unfortunate statistical accident.
It is a predictable, state-subsidized fatality.
THE COGNITIVE GUILLOTINE:
COMMERCIAL THC, ALCOHOL, AND THE ENGINEERED ASSEMBLY LINE TO THE CEMETERY
If an adversary wanted to
design a domestic population incapable of basic survival, they could not
construct a more efficient pipeline than the modern American addiction
paradigm. To understand how a microscopic speck of a 66-year-old discarded
chemical like cychlorphine guarantees instant death, you have to look at the
engineered state of the human target walking into the crosshairs.
THE "NEW
STUPID": HIGH-POTENCY CANNABIS AS THE COGNITIVE NEUTRALIZER
The romanticized myth of
marijuana as a harmless, natural herb plucked from a 1969 Woodstock pasture is
a marketing fabrication. The ditch-weed of the 1960s and 1970s carried a
tetrahydrocannabinol (THC) concentration between 1% and 3%. Today’s state-licensed
commercial dispensary menu features genetically engineered hybrid flower
testing at 25% to 35% THC, and solvent-extracted concentrates, distillates, and
vapes reaching 90% purity. This is not the gentle mood-lifter of your parents'
generation; it is an industrial neurotoxin that chemically strips away
executive functioning, prefrontal cortex inhibition, and situational survival
instincts.
As established in Are
You Stoned or Stupid?, the practical outcome of chronic saturation with
supercharged THC is the systematic dismantling of critical reasoning. It does
not simply relax the user; it induces an intellectual paralysis—the "new
stupid"—leaving the user incapable of assessing obvious physical hazards or
calculating risk. Yet, under the political stampede to commercialize and tax it
in all 50 states, this profound cognitive depressant is handed out with a
societal clean bill of health.
THE PERMISSIVE MAT
BLINDSPOT: FREE PASSES ON WEED AND ALCOHOL
Step inside the average
Medicaid-funded Medication-Assisted Treatment clinic and observe the
administrative theater. The patient is handed a daily dose of synthetic
narcotics—methadone or buprenorphine—often paired with towering psychiatric
cocktails of gabapentinoids, sleep aids, and mood stabilizers that push central
nervous system depressant levels hundreds of percent past Physicians' Desk
Reference safety baselines. One only needs to examine the devastating
real-world precedent of the Lindsay Clancy tragedy to see the catastrophic
neurological break that occurs when a patient is subjected to over a dozen
distinct mind-altering medications in a compressed four-month span.
Yet, despite this
hair-trigger chemical baseline, the clinic’s testing protocols look the other
way. Because commercial cannabis is state-sanctioned, the clinic does not flag
or discipline for high-potency THC. Because alcohol is legal, a patient maintained
on daily opioids is given a free pass to binge drink over the weekend or wash
down their evening dose with a six-pack. The clinical bureaucracy declares that
because the patient's primary diagnosis was an opioid dependency, flooding
their bloodstream with alcohol and neuro-paralyzing THC is perfectly acceptable
"harm reduction." It is an administrative license to walk through the
world in a state of permanent, multi-layered chemical stupor.
THE RECEPTOR CON: SAME
TARGET, SAME CRASH, DIFFERENT DOOR
The clinical excuse that
an opioid patient can safely consume alcohol because their "problem was
narcotics" is one of the most intellectually bankrupt lies in modern
addiction medicine. To the human central nervous system, this distinction does
not exist. While alcohol enters through the stomach and opioids enter through a
pill, a line, or a vein, both substances converge on the exact same
neurological real estate: the mesolimbic dopamine reward pathway and the vital
breathing centers of the brainstem.
Opioids bind directly to
the opioid receptors, which
sit heavily clustered across the ventral tegmental area and the medullary
respiratory center in the brainstem. Alcohol works as a dirty pharmacological
bomb: it floods gamma-aminobutyric acid (GABA) receptors to shut down neurological
firing, while concurrently stimulating the release of endogenous
beta-endorphins that lock onto those very same opioid receptors. At the
cellular level, alcohol triggers the identical downstream opioid cascades,
paralyzing the prefrontal cortex and turning down the brainstem's carbon
dioxide drive. When a clinic tells an opioid patient that drinking is fine
because "alcohol isn't an opiate," they are ignoring fundamental
neurobiology: it is the exact same receptor system, the exact same neurological
sedation, and the exact same respiratory brake pedal—just delivered through a
different ingestion tract.
THE POLYSUBSTANCE DEAD
END: ZERO DEFENSE AGAINST CYCHLORPHINE
Take an individual in
this exact state: brainstem already suppressed by high-dose daily methadone,
neurological executive function knocked offline by 30% dispensary weed, balance
and reflex control dull from weekend alcohol intake, and psychiatric meds running
at maximum volume. They have had a catastrophic week—lost their job, suffered a
devastating breakup, or buried a family pet. Living in an engineered state of
permanent pre-relapse with zero emotional coping mechanisms and zero
abstinence-based tools, the biological drive to escape emotional pain is
absolute.
They reach for what they
believe is a street Xanax or a counterfeit pain pill to numb the ache. Because
their cognitive radar was dismantled by commercial THC and alcohol, they lack
the basic survival skepticism to question the tablet. And because their bloodstream
is already drowning in an MAT-prescribed depressant cocktail sharing the exact
same sedated neurological pathways, their biological margin for survival is
non-existent. When the pill delivers an invisible micro-speck of
cychlorphine—ten times stronger than fentanyl, 1,000 times stronger than
morphine—the pharmacological reaction is instantaneous. There is no biological
reserve left to fight. The respiratory center collapses on impact, the chest
locks tight, and the individual transitions from state-sponsored "symptom
management" to a horizontal corpse on the coroner’s slab.
THE DEMOGRAPHIC
SLAUGHTER: ACCELERATING THE DAILY BODY COUNT
Look at the intake
manifests of local county morgues: these are not 55, 65, or 75-year-old
retirees succumbing to cychlorphine hotspots. The decedents are predominantly
twenty- and thirty-somethings—young people systematically fed into a predatory
medical and penal apparatus that dismantled long-term, 12-step abstinence
recovery centers and replaced them with lifetime chemical subscriptions.
Currently, the daily
American casualty rate from drug poisonings sits at a relentless baseline of
roughly 700 dead citizens every single day. When you apply an actuarial
probability index that adds the projected 25% to 45% fatality escalation
directly driven by orphine-class compounds like cychlorphine infiltrating an
already MAT-saturated, cannabis-dulled youth population, the arithmetic is
horrifying. That baseline surges from 700 bodies a day to well over 900 to
1,000 corpses every single 24 hours. That is an additional 70,000 to 100,000
young lives wiped out annually, pushing the cumulative human toll toward
catastrophic historical heights.
This is the real dividend
of a policy managed by 31,000 judges, 82,000 prosecutors, complicit
correctional facilities, and mega-pharmaceutical corporations backed by a
blind, fee-collecting legislative apparatus. By trading authentic, lifelong
sobriety for a multi-trillion-dollar chemical management racket, society did
not protect our youth; it merely engineered a faster, state-subsidized route to
the cemetery.
EXECUTIVE SUMMARY AND
CALL TO ACTION: LIVE THE SOLUTION, NOT THE PROBLEM
Nobody ever woke up at
five years old and declared, "I can't live without a fifth of Jack Daniels
today." I have never seen a seven-year-old determine that their life in
the second grade would be vastly improved by a cocaine habit, nor do nine-year-olds
inherently seek out opioid dependency. However, once the genetic predisposition
is triggered and those initial choices are made, the option to simply say no is
removed from the equation until the individual is given new data and a new way
to live. The choice itself is brutally binary: if you have a problem, do not
feed it. If you do not have a problem, do not start one.
There is no opioid crisis
in America; there is a treatment crisis. When the government codified
Supplemental Security Income (SSI) regulations in 1996, and when the American
Medical Association evaluated addiction, the conclusion was unambiguous: the
cure for alcoholism and drug addiction is complete abstinence. Yes, individuals
will be physically and emotionally uncomfortable in withdrawal. Providing them
with proper, medically supervised facilities solves that hurdle. True recovery
demands that people choose whether they want to continue engaging in their
destructive behaviors; if they do, they must suffer the natural consequences of
those actions. Instead, society invented the myth of "harm reduction"
and "symptom management"—a system so grotesquely broken that 87% of
chemically saturated users are routinely let out of jail simply because they
are so toxic the local municipalities refuse to risk a wrongful death lawsuit
on their watch.
Albert Einstein famously
noted that the same mind that caused a problem cannot fix the problem. By that
exact logic, taking away all the known, long-term recovery options that
actually worked—programs that historically produced a 91% success rate after five
years—and replacing them with a strategy of giving more drugs to drug addicts
and letting alcoholics drink is not a medical breakthrough. It is
institutionalized insanity. When you strip away abstinence and substitute it
with lifetime pharmacological subscriptions, all you have to do is look at the
national death clock and the overflowing cemeteries to realize it is not a
solution. The flat line of state-sponsored symptom management will only grow
horizontally, while the vertical line for true, abstinence-based recovery
remains completely flat until the system is forced into a hard reset.
Every single element of
this catastrophe is resolvable. The issue is not a lack of scientific
understanding; it is a lack of legislative willpower and an absolute addiction
to healthcare inflation. We cover the precise mechanics of this collapse—and
the exact blueprint for its resolution—in The Assassination of Recovery: The
Whistleblower's Dossier on the $35.9 Trillion Extraction and America's
Deadliest Medical Fraud. The entire evidentiary dossier is already in the
government's hands. It was requested by the House Oversight Committee; it sits
in the possession of the House Judiciary Committee as the relator of record,
and it was delivered to the Senate and executive branches as far back as
February. Yet, here we are, watching the legislative apparatus protect a $35.9
trillion billing machine and add to the national debt while the bodies pile up.
They legislated this problem, whether through ignorance or deliberate indifference.
We have a comprehensive
initiative designed to return to the successful, drug- and alcohol-free model
where individuals are taught how to become functional members of society
again—restoring their lives to be happy, joyous, and free. We invite you to explore
this framework and join the fight by visiting us at Help2LIR. If you know a
legislator, a policymaker, or anyone standing in the way of real recovery, turn
them onto us. Send them our way and make them read The Assassination of
Recovery. It is time to stop feeding the bureaucracy of death.
Live in the solution, not
the problem.
Read The Assassination of Recovery: The Whistleblower's Dossier on the $35.9 Trillion Extraction and America's Deadliest Medical Fraud.
Retail Purchase Links Here: Amazon | Barnes & Noble | Kobo | Google Play | Apple Books | Draft2Digital | IngramSpark
FREE: Audio Sample, The Assassination of Recovery: The Whistleblower's Dossier on the $35.9 Trillion Extraction and America's Deadliest Medical Fraud
Purchase the full 8 hour 55 min. audiobook:
